Treated with IL-22, RKO colorectal carcinoma cells showed enhanced cell proliferation and reduction in apoptosis, whereas these effects could be eliminated after the addition of STAT3 inhibitor S3I-201 118. The gene discussed is STAT3; the disease is colorectal carcinoma.